FI881340A - Antitumoriska aemnen. - Google Patents

Antitumoriska aemnen. Download PDF

Info

Publication number
FI881340A
FI881340A FI881340A FI881340A FI881340A FI 881340 A FI881340 A FI 881340A FI 881340 A FI881340 A FI 881340A FI 881340 A FI881340 A FI 881340A FI 881340 A FI881340 A FI 881340A
Authority
FI
Finland
Prior art keywords
alkyl
hydrogen
alkoxy
alkylthio
aemnen
Prior art date
Application number
FI881340A
Other languages
English (en)
Other versions
FI881340A0 (fi
Inventor
Leslie Richard Hughes
Original Assignee
Ici Plc
Nat Res Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ici Plc, Nat Res Dev filed Critical Ici Plc
Publication of FI881340A0 publication Critical patent/FI881340A0/fi
Publication of FI881340A publication Critical patent/FI881340A/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/95—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4
    • C07D239/96—Two oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/88—Oxygen atoms
    • C07D239/90—Oxygen atoms with acyclic radicals attached in position 2 or 3

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FI881340A 1987-03-25 1988-03-21 Antitumoriska aemnen. FI881340A (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB878707053A GB8707053D0 (en) 1987-03-25 1987-03-25 Anti-tumour agents

Publications (2)

Publication Number Publication Date
FI881340A0 FI881340A0 (fi) 1988-03-21
FI881340A true FI881340A (fi) 1988-09-26

Family

ID=10614570

Family Applications (1)

Application Number Title Priority Date Filing Date
FI881340A FI881340A (fi) 1987-03-25 1988-03-21 Antitumoriska aemnen.

Country Status (17)

Country Link
US (1) US4981856A (fi)
EP (1) EP0284338B1 (fi)
JP (1) JP2577036B2 (fi)
AT (1) ATE98956T1 (fi)
AU (1) AU600105B2 (fi)
CA (1) CA1301756C (fi)
DE (1) DE3886435T2 (fi)
DK (1) DK167013B1 (fi)
ES (1) ES2061641T3 (fi)
FI (1) FI881340A (fi)
GB (2) GB8707053D0 (fi)
GR (1) GR3010208T3 (fi)
IL (1) IL85696A (fi)
NO (1) NO881300L (fi)
NZ (1) NZ224010A (fi)
PT (1) PT87074B (fi)
ZA (1) ZA881885B (fi)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8727737D0 (en) * 1987-11-26 1987-12-31 Ici Plc Antitumour agents
GB8809978D0 (en) * 1988-04-27 1988-06-02 Ici Plc Anti-tumour agents
EP0365763A1 (en) * 1988-09-30 1990-05-02 Agouron Pharmaceuticals, Inc. Antiproliferative cyclic compounds
US5252573A (en) * 1988-12-15 1993-10-12 Imperial Chemical Industries Plc Anti-tumor agents
GB8829296D0 (en) * 1988-12-15 1989-01-25 Ici Plc Anti-tumour compounds
US5160727A (en) * 1990-02-13 1992-11-03 Warner-Lambert Company Tumor cell sensitization method using quinazolinedione derivatives
AU640016B2 (en) * 1990-05-30 1993-08-12 Imperial Chemical Industries Plc Hydroquinazoline derivatives
GB9013615D0 (en) * 1990-06-19 1990-08-08 Wellcome Found Pharmaceutical compounds
GB9105771D0 (en) * 1991-03-19 1991-05-01 Cancer Res Inst Royal Anti-cancer compounds
US5145854A (en) * 1991-11-27 1992-09-08 Nair Madhavan G 1-formyl-5,8,10-trideazafolates
GB9205320D0 (en) * 1992-03-11 1992-04-22 Ici Plc Anti-tumour compounds
GB9205907D0 (en) * 1992-03-18 1992-04-29 Cancer Res Inst Royal Anti-cancer compounds
US5430148A (en) * 1992-03-31 1995-07-04 Agouron Pharmaceuticals, Inc. Antiproliferative quinazolines
GB9223352D0 (en) * 1992-11-06 1992-12-23 Ici Plc Tricyclic compounds
DE4421884A1 (de) 1994-06-23 1996-01-04 Hoechst Ag Verfahren zur Herstellung von Hydroxycarbonsäureaniliden
DE4427837A1 (de) 1994-08-05 1996-02-08 Hoechst Ag Verfahren zur Herstellung von O-Acylglykolsäureaniliden
DE19504225A1 (de) 1995-02-09 1996-08-14 Hoechst Ag Verfahren zur Herstellung von O-Acyloxycarbonsäureaniliden
US5739330A (en) * 1996-02-05 1998-04-14 Hoechst Celanese Corporation Process for preparing quinazolones
GB9904275D0 (en) 1999-02-24 1999-04-21 Cancer Res Campaign Tech Anti-cancer compounds
US6545004B1 (en) 1999-10-27 2003-04-08 Cytokinetics, Inc. Methods and compositions utilizing quinazolinones
US7230000B1 (en) * 1999-10-27 2007-06-12 Cytokinetics, Incorporated Methods and compositions utilizing quinazolinones
AU2002346471A1 (en) * 2001-11-20 2003-06-10 Cytokinetics, Inc. Process for the racemization of chiral quinazolinones
WO2003054155A2 (en) 2001-12-19 2003-07-03 Bristol-Myers Squibb Company Pichia pastoris formate dehydrogenase and uses therefor
AU2003213092A1 (en) * 2002-02-15 2003-09-09 Smithkline Beecham Corporation Syntheses of quinazolinones
JP2005530785A (ja) * 2002-05-09 2005-10-13 サイトキネティクス・インコーポレーテッド 化合物、組成物、及び方法
BR0309892A2 (pt) * 2002-05-09 2011-04-05 Cytokinetics Inc composto, composição, métodos para modular a atividade da cinesina de ksp, para inibir a ksp, e para o tratamento de uma doença proliferativa celular, e, uso de um composto
US7038048B2 (en) 2002-05-23 2006-05-02 Cytokinetics, Inc. 3H-pyridopyrimidin-4-one compounds, compositions, and methods of their use
EP1556357A4 (en) * 2002-06-14 2006-09-13 Cytokinetics Inc COMPOUNDS, COMPOSITIONS AND METHODS
AU2003256805A1 (en) * 2002-07-23 2004-02-09 Cytokinetics, Inc. Compounds compositions and methods
US20040048853A1 (en) * 2002-08-21 2004-03-11 Gustave Bergnes Compounds, compositions, and methods
EP1558083A4 (en) * 2002-09-30 2008-04-16 Cytokinetics Inc COMPOUNDS, COMPOSITIONS AND METHODS
GB0317631D0 (en) * 2003-07-28 2003-08-27 Btg Int Ltd Synthetic method
JP2007510652A (ja) * 2003-11-03 2007-04-26 サイトキネティクス・インコーポレーテッド ピリミジン−４−オン化合物、組成物、および方法
EP1680420A4 (en) * 2003-11-07 2008-09-24 Cytokinetics Inc COMPOUNDS, COMPOSITIONS AND METHODS
JP2007513154A (ja) * 2003-12-08 2007-05-24 サイトキネティクス・インコーポレーテッド 化合物、組成物及び方法
JP2010530885A (ja) * 2007-06-22 2010-09-16 アークル インコーポレイテッド キナゾリノン化合物およびその使用方法
US8940742B2 (en) 2012-04-10 2015-01-27 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof
WO2015051241A1 (en) 2013-10-04 2015-04-09 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof
MX2016004340A (es) 2013-10-04 2016-08-08 Infinity Pharmaceuticals Inc Compuestos heterociclicos y usos de los mismos.
PT3119397T (pt) 2014-03-19 2022-04-11 Infinity Pharmaceuticals Inc Compostos heterocíclicos para utilização no tratamento de distúrbios mediados por pi3k-gama
US9708348B2 (en) 2014-10-03 2017-07-18 Infinity Pharmaceuticals, Inc. Trisubstituted bicyclic heterocyclic compounds with kinase activities and uses thereof
US10160761B2 (en) 2015-09-14 2018-12-25 Infinity Pharmaceuticals, Inc. Solid forms of isoquinolinones, and process of making, composition comprising, and methods of using the same
WO2017161116A1 (en) 2016-03-17 2017-09-21 Infinity Pharmaceuticals, Inc. Isotopologues of isoquinolinone and quinazolinone compounds and uses thereof as pi3k kinase inhibitors
US10919914B2 (en) 2016-06-08 2021-02-16 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2065653B (en) * 1979-12-19 1983-03-09 Nat Res Dev Anti-cancer quinazoline derivatives
GB8513754D0 (en) * 1985-05-31 1985-07-03 Jones T R Anti-cancer quinazoline derivatives
GB8607683D0 (en) * 1986-03-27 1986-04-30 Ici Plc Anti-tumor agents

Also Published As

Publication number Publication date
US4981856A (en) 1991-01-01
ATE98956T1 (de) 1994-01-15
IL85696A (en) 1993-05-13
EP0284338A2 (en) 1988-09-28
PT87074B (pt) 1992-07-31
GB2202847A (en) 1988-10-05
JPS63255270A (ja) 1988-10-21
DE3886435T2 (de) 1994-04-14
GB8805982D0 (en) 1988-04-13
CA1301756C (en) 1992-05-26
ZA881885B (en) 1988-09-26
JP2577036B2 (ja) 1997-01-29
ES2061641T3 (es) 1994-12-16
DK168488A (da) 1988-09-26
AU1327988A (en) 1988-09-29
DE3886435D1 (de) 1994-02-03
NO881300L (no) 1988-09-26
AU600105B2 (en) 1990-08-02
PT87074A (pt) 1988-04-01
NZ224010A (en) 1990-12-21
GB2202847B (en) 1990-06-06
FI881340A0 (fi) 1988-03-21
DK168488D0 (da) 1988-03-25
GB8707053D0 (en) 1987-04-29
GR3010208T3 (fi) 1994-03-31
DK167013B1 (da) 1993-08-16
NO881300D0 (no) 1988-03-24
EP0284338B1 (en) 1993-12-22
EP0284338A3 (en) 1989-05-17

Similar Documents

Publication Publication Date Title
FI881340A (fi) Antitumoriska aemnen.
IE870699L (en) Quinazoline derivatives
DE3588100D1 (de) Carbamidsäureester-Derivate, Mittel und Herstellungsverfahren
FI885559A0 (fi) Anvaendning av d-cykloserin och dess prodrug som cognition oekande medel.
ZA911502B (en) A pharmaceutical solution
NO301543B1 (no) 2-£4-(kinazolinylmetylamino)benzamido|-4-(tetrazolyl)smörsyrederivater med anti-tumor-aktivitet
ES2063452T3 (es) Preparacion y uso de esteres y derivados de n-yodopropargil oxicarbonil aminoacido como agentes antimicrobianos.
ATE24726T1 (de) 4-aether-derivate von 2-azetidinon-1-sulfonsaeuren.
ES8402581A1 (es) Un procedimiento para preparar derivados de imidazol y triazol.
DK377687A (da) Triazol-fungicidpraeparater
EP0219835A3 (en) Acylaminoaryloxy and arylthio pyrimidines
DE3160598D1 (en) Carbonyl-amino-urethanes and herbicidal and fungicidal compositions containing them
ATE24181T1 (de) 2-oxo-1-(thiophosphon- oder thiophosphinsaeure)azetidine.
GR3025084T3 (en) Acrylic derivatives of 2-thiazolypyrroles having a fungicidal activity
AU555944B2 (en) Phosphorus derivatives of carbamimidothioic esters

Legal Events

Date Code Title Description
FD Application lapsed
MM Patent lapsed

Owner name: IMPERIAL CHEMICAL INDUSTRIES PLC

Owner name: NATIONAL RESEARCH DEVELOPMENT